GLP 1 News and Research

RSS
Pizza study finds the body's metabolism to be good at coping with over-indulgence

Pizza study finds the body's metabolism to be good at coping with over-indulgence

Chemist develops new drug to treat type 2 diabetes without undesired side effects

Chemist develops new drug to treat type 2 diabetes without undesired side effects

Heart failure poses the greatest risk of death for people with type 2 diabetes

Heart failure poses the greatest risk of death for people with type 2 diabetes

GLP-1-based medicine for diabetic patients does not cause pancreatitis

GLP-1-based medicine for diabetic patients does not cause pancreatitis

New potential treatment candidate identified for early type 2 diabetic retinopathy

New potential treatment candidate identified for early type 2 diabetic retinopathy

Could DPP4 inhibitors help treat COVID-19?

Could DPP4 inhibitors help treat COVID-19?

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

People with type 2 diabetes and heart disease may benefit from newer therapies

People with type 2 diabetes and heart disease may benefit from newer therapies

Two newer types of diabetes medications show heart and kidney benefits

Two newer types of diabetes medications show heart and kidney benefits

Gene therapy investigators can greatly benefit from National Gene Vector Biorepository

Gene therapy investigators can greatly benefit from National Gene Vector Biorepository

Targeted combinatorial drug treatment restores beta cell function in mice

Targeted combinatorial drug treatment restores beta cell function in mice

Novel drug combination discovered to induce high rates of human beta cell proliferation

Novel drug combination discovered to induce high rates of human beta cell proliferation

MR Solutions installs 3T PET-MR system at Western University’s ImPaKT facility

MR Solutions installs 3T PET-MR system at Western University’s ImPaKT facility

Penn researchers receive nearly $5 million to reduce opioid cravings

Penn researchers receive nearly $5 million to reduce opioid cravings

GLP-1 receptors could serve as targets for novel medications to treat opioid use disorder

GLP-1 receptors could serve as targets for novel medications to treat opioid use disorder

Study explores distribution of new diabetes cases and specialist density in the U.S.

Study explores distribution of new diabetes cases and specialist density in the U.S.

Tecan to launch Fluent Gx Automation Workstation for use in regulated laboratories

Tecan to launch Fluent Gx Automation Workstation for use in regulated laboratories

New injection helps reduce body weight, glucose levels in patients with obesity

New injection helps reduce body weight, glucose levels in patients with obesity

SGLT-2 inhibitors do not increase the risk of UTIs in diabetics, concludes study

SGLT-2 inhibitors do not increase the risk of UTIs in diabetics, concludes study

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes